Literature DB >> 24333708

K(V)7 potassium channels: a new therapeutic target in smooth muscle disorders.

Jennifer B Stott1, Thomas A Jepps1, Iain A Greenwood2.   

Abstract

Potassium channels are key regulators of smooth muscle tone, with increases in activity resulting in hyperpolarisation of the cell membrane, which acts to oppose vasoconstriction. Several potassium channels exist within smooth muscle, but the KV7 family of voltage-gated potassium channels have been identified as being crucial mediators of this process in a variety of smooth muscle. Recently, KV7 channels have been shown to be involved in the pathogenesis of hypertension, as well as being implicated in other smooth muscle disorders, providing a new and inviting target for smooth muscle disorders.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24333708     DOI: 10.1016/j.drudis.2013.12.003

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  37 in total

1.  KV7 Channel Pharmacological Activation by the Novel Activator ML213: Role for Heteromeric KV7.4/KV7.5 Channels in Guinea Pig Detrusor Smooth Muscle Function.

Authors:  Aaron Provence; Damiano Angoli; Georgi V Petkov
Journal:  J Pharmacol Exp Ther       Date:  2017-10-30       Impact factor: 4.030

2.  From pan-reactive KV7 channel opener to subtype selective opener/inhibitor by addition of a methyl group.

Authors:  Sigrid Marie Blom; Mario Rottländer; Jan Kehler; Christoffer Bundgaard; Nicole Schmitt; Henrik Sindal Jensen
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

3.  Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370.

Authors:  T A Jepps; B H Bentzen; J B Stott; O V Povstyan; K Sivaloganathan; W Dalby-Brown; I A Greenwood
Journal:  Br J Pharmacol       Date:  2014-08-14       Impact factor: 8.739

4.  KCNQ5 activation is a unifying molecular mechanism shared by genetically and culturally diverse botanical hypotensive folk medicines.

Authors:  Rían W Manville; Jennifer van der Horst; Kaitlyn E Redford; Benjamin B Katz; Thomas A Jepps; Geoffrey W Abbott
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

5.  KV7 channels in the human detrusor: channel modulator effects and gene and protein expression.

Authors:  Riccardo Bientinesi; Cesare Mancuso; Maria Martire; Pier Francesco Bassi; Emilio Sacco; Diego Currò
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-10-19       Impact factor: 3.000

6.  The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility.

Authors:  Aaron Provence; John Malysz; Georgi V Petkov
Journal:  J Pharmacol Exp Ther       Date:  2015-06-18       Impact factor: 4.030

7.  Kcne4 Deletion Sex-Dependently Alters Vascular Reactivity.

Authors:  Geoffrey W Abbott; Thomas A Jepps
Journal:  J Vasc Res       Date:  2016-10-07       Impact factor: 1.934

8.  4-Aminopyridine: a pan voltage-gated potassium channel inhibitor that enhances Kv 7.4 currents and inhibits noradrenaline-mediated contraction of rat mesenteric small arteries.

Authors:  Makhala M Khammy; Sukhan Kim; Bo H Bentzen; Soojung Lee; Inyeong Choi; Christian Aalkjaer; Thomas A Jepps
Journal:  Br J Pharmacol       Date:  2018-01-05       Impact factor: 8.739

9.  Investigating the Role of G Protein βγ in Kv7-Dependent Relaxations of the Rat Vasculature.

Authors:  Jennifer B Stott; Vincenzo Barrese; Malavika Suresh; Shirou Masoodi; Iain A Greenwood
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

10.  Molecular and functional characterization of Kv 7 channels in penile arteries and corpus cavernosum of healthy and metabolic syndrome rats.

Authors:  T A Jepps; S P Olesen; I A Greenwood; T Dalsgaard
Journal:  Br J Pharmacol       Date:  2016-02-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.